The Kimberly-Clark/Kenvue transaction is one of the worst-received major merger deals in recent years. Investors wondered why ...

Kimberly-Clark has agreed to acquire Johnson & Johnson (J&J) consumer health spinout Kenvue for $48.7bn. One of America’s ...

In other news, Apple suppliers Qorvo and Skyworks plan to combine and metal card maker Composecure offers a bid for Husky ...

Despite a headline beat and decent revenue forecast, the poor reaction to the update from AI and data analytics darling ...

The recent publicity could allow the company to get a good deal on Kenvue, which makes Tylenol, Band-Aids, and other ...

The consumer health and wellness giants are both Dividend Kings, with more than 50 years of consecutive annual payout ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a huge consumer ...

Palantir Technologies, which came into the day with a stunning 165% gain for the year so far, rose another 3.3%. Traders ...

A £30 billion takeover shakes up the consumer health sector as Kimberly-Clark, the maker of Huggies nappies, prepares to ...

Tylenol faces scrutiny over pregnancy use and autism links, despite scientific bodies finding no firm evidence. While ...

Kimberly-Clark said the combination would create a company with $32 billion in revenue and allow it to surpass Unilever Plc ...